STEFANI BEVERLIN: Open Payments
NPI 1497884134 · EFFINGHAM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 16 payments from 8 companies in 2025. Trend: 2023 $327 · 2024 $348 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $94 |
| Sage Therapeutics, LLC | 3 | $69 |
| Astellas Pharma US Inc | 2 | $31 |
| Exeltis, USA Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Organon LLC | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
Products named: GEMTESA, ZURZUVAE, Veozah, SLYND, Qelbree, NEXPLANON, ABRYSVO, ZEPBOUND.
Industry payments across IL — which companies pay providers there.
